ALL TESTS IN CHRONOLOGICAL ORDER - 7th
| A = Type | B = Category | C = Test | D = Result | E = Unit |
| F = Alteration | G = Expected Value | H = Date | I = Place |
| A | B | C | D | E | F | G | H | I |
| BLO | HEMA | hematocrit | 38.4% 0.38 | L | 10/1/96 | Verona | ||
| BLO | HEMA | Hemoglobin | 12 | g/dl | 10/1/96 | Verona | ||
| BLO | HEMA | herythrocyte | 4.64 | E+12/L | 10/1/96 | Verona | ||
| BLO | HEMA | MCV | 82.70 | l | A | 10/1/96 | Verona | |
| BLO | HEMA | MCH | 25;8 | pg | 10/1/96 | Verona | ||
| BLO | HEMA | MCHC | 31.2 | g/dl | 10/1/96 | Verona | ||
| BLO | HEMA | RDW | 12.8 | % | 10/1/96 | Verona | ||
| BLO | HEMA | platelet | 254 | E+09/L | 10/1/96 | Verona | ||
| BLO | HEMA | MPV | 9.5 | £L | 10/1/96 | Verona | ||
| BLO | HEMA | PDW | 43.2 | % | 10/1/96 | Verona | ||
| BLO | HEMA | PCT | 0.24 | % | 10/1/96 | Verona | ||
| BLO | HEMA | leucocytes | 5.8 | E+09/L | A | 10/1/96 | Verona | |
| BLO | HEMA | E+09/L % | 10/1/96 | Verona | ||||
| BLO | HEMA | neutrophil | 2.12 36.6 | 10/1/96 | Verona | |||
| BLO | HEMA | lymphocyte | 3.11 53.7 | 10/1/96 | Verona | |||
| BLO | HEMA | monocytes | 0.24 4.2 | 10/1/96 | Verona | |||
| BLO | HEMA | eosinophiles | 0.08 1.4 | 10/1/96 | Verona | |||
| BLO | HEMA | basophiles | 0.03 0.6 | 10/1/96 | Verona | |||
| BLO | HEMA | luc | 0.2 3.5 | 10/1/96 | Verona | |||
| BLO | HEMA | total bilirubin | 0.3 | mg/dl | 10/1/96 | Verona | ||
| BLO | HEMA | 5.1 | umol/L | 10/1/96 | Verona | |||
| BLO | HEMA | direct bilirubin | 0.1 | mg/dl | 10/1/96 | Verona | ||
| BLO | HEMA | 1.71 | umol/L | 10/1/96 | Verona | |||
| BLO | bio.pro | ALT | 22 | U/L | 10/1/96 | Verona | ||
| BLO | bio.pro | AST | 29 | U/L | 10/1/96 | Verona | ||
| BLO | bio.pro | GGT | 37 | U/L | A | inf to 33 | 10/1/96 | Verona |
| BLO | bio.pro | LD | 154 | U/L | 10/1/96 | Verona | ||
| BLO | END | T3 | 1.6 | ug/L | 10/1/96 | Verona | ||
| BLO | END | 2.54 | nmol/L | 1.08-3.08 | 10/1/96 | Verona | ||
| BLO | END | T4 | 86 | ug/L | 10/1/96 | Verona | ||
| BLO | END | 110 | nmol/L | 51.2-256 | 10/1/96 | Verona | ||
| BLO | END | FT4 | 8.3 | ng/L | 10/1/96 | Verona | ||
| BLO | END | 10.6 | pmol/L | 7.55-20.5 | 10/1/96 | Verona | ||
| BLO | END | TSH | 2 | mUI/L | 0.3-3 | 10/1/96 | Verona | |
| BLO | IMM | HBsAg | negativo | 10/1/96 | Verona | |||
| BLO | IMM | anti Hbs Ag | 0 | 10/1/96 | Verona | |||
| BLO | IMM | ANTI CORE HBV | negativo | 10/1/96 | Verona | |||
| BLO | IMM | ANTI HAV TOTALI | negativo | 10/1/96 | Verona | |||
| BLO | IMM | ANTI HAV IgM | negativo | 10/1/96 | Verona | |||
| BLO | IMM | Anti HCV (MEIA 3° Gen.) | negativo | 10/1/96 | Verona | |||
| BLO | IMM | Antibodies anti nucleo (ANA co IFA) | negativo | 10/1/96 | Verona | |||
| BLO | IMM | antibodies anti MAG | negativo | 10/1/96 | Verona | |||
| BLO | IMM | Mielina | Assoni | Endo/perinevrio | 10/1/96 | Verona | ||
| BLO | IMM | IgM 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | IgG 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | IgA 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | Kappa 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | Lambda 0 | 0 | 0 | 10/1/96 | Verona | ||
| BLO | IMM | Immunoglobulins | 10/1/96 | Verona | ||||
| BLO | IMM | IgA | 1.79 | g/l | 0.50-2.30 | 10/1/96 | Verona | |
| BLO | IMM | IgG | 10.8 | g/L | 4.20-15.5 | 10/1/96 | Verona | |
| BLO | IMM | IgM | 1.72 | g/L | A | 0.20-1.50 | 10/1/96 | Verona |
| BLO | IMM | subclass IgG | 10/1/96 | Verona | ||||
| BLO | IMM | G1 | 5610 | mg/L | 10/1/96 | Verona | ||
| BLO | IMM | G2 | 4480 | mg/L | A | 10/1/96 | Verona | |
| BLO | IMM | G3 | 246 | mg/L | 10/1/96 | Verona | ||
| BLO | IMM | G4 | 3890 | mg/L | A | 10/1/96 | Verona | |
| BLO | IMM | complemento C3 | 0.94 | g/L | 10/1/96 | Verona | ||
| BLO | IMM | complemento C4 | 0.23 | g/L | 10/1/96 | Verona | ||
| BLO | IMM | CH50 | 120 | Emol/ml | 10/1/96 | Verona | ||
| BLO | IMM | LYMPHOCYTES | 10/1/96 | Verona | ||||
| BLO | IMM | Total lymphocytes cell/mm3 | 3114 | 10/1/96 | Verona | |||
| BLO | IMM | Total lymphocytes % | 53.7 | 10/1/96 | Verona | |||
| BLO | IMM | T LYMPHOCYTES CD3 + | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 2534 | 10/1/96 | Verona | |||
| BLO | IMM | - % dei linf.T nei Linf.Totali CD3+ | 81.4 | 10/1/96 | Verona | |||
| BLO | IMM | -% doppi posit.in T:CD4+CD8+in CD3+ 18.4 | 0.5 | 10/1/96 | Verona | |||
| BLO | IMM | - % doppi negat. inT. CD4-CD8-in CD3+ | 18.4 | 10/1/96 | Verona | |||
| BLO | IMM | T 4 LYMPHOCYTES CD3+ CD4+ | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 1304 | 10/1/96 | Verona | |||
| BLO | IMM | -% T4 Lymp. in total Lymp. CD3+CD4+ | 41.9 | 10/1/96 | Verona | |||
| BLO | IMM | -% T4 Lymp. in T Lymp. CD4+ in CD3+ | 52 | 10/1/96 | Verona | |||
| BLO | IMM | T 8 LYMPHOCYTES CD3+ CD8+ | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 753 | 10/1/96 | Verona | |||
| BLO | IMM | -% T 8 Lymp in Total Lymp CD3+ CD8+ | 24.2 | 10/1/96 | Verona | |||
| BLO | IMM | - % T 8 Lymp.in T Lymp CD8+ in CD3+ | 29.5 | 10/1/96 | Verona | |||
| BLO | IMM | - % CD 28+ in T 8: CD28+ in CD8+ | 76 | 10/1/96 | Verona | |||
| BLO | IMM | - % CD57+ in T 8: CD57+ in CD8+ | 7 | 10/1/96 | Verona | |||
| BLO | IMM | ratio 28/57 in T 8: CD28+/CD57+ in CD8+ 10.85 | 10.85 | 10/1/96 | Verona | |||
| BLO | IMM | ratio T4/T8 | 1.73 | 10/1/96 | Verona | |||
| BLO | IMM | B LYMPHOCYTES CD19+ | 10/1/96 | Verona | ||||
| BLO | IMM | - cells / mm3 | 392 | 10/1/96 | Verona | |||
| BLO | IMM | -% B Lymp. in total Lymp. CD 19+ | 12.6 | 10/1/96 | Verona | |||
| BLO | IMM | NK LYMPHOCYTES | 10/1/96 | Verona | ||||
| BLO | IMM | - cells/ MM3 | 183 | 10/1/96 | Verona | |||
| BLO | IMM | - % NK Lymp. in Tot. Lymp | 10/1/96 | Verona | ||||
| BLO | IMM | CD16+ e/o CD56+ CD3- | 5.9 | 10/1/96 | Verona | |||
| BLO | IMM | - % T Lymp with NK activity: | 10/1/96 | Verona | ||||
| BLO | IMM | CD16+ e/o CD56 + CD3+ | 1.6 | 10/1/96 | Verona | |||
| BLO | IMM | CD18+ in CD8+ | 99.60% | 10/1/96 | Verona | |||
| BLO | IMM | CD18+ in CD4+ | 95% | 10/1/96 | Verona | |||
| BLO | IMM | CD11+ in CD8+ | 99.10% | 10/1/96 | Verona | |||
| BLO | IMM | CD11+ in CD4+ | 89.70% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RO+ in CD8+ | 49% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RO+ in CD4+ | 26% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RA+ IN CD8+ | 87.40% | 10/1/96 | Verona | |||
| BLO | IMM | CD45RA+ in CD4+ | 75% | 10/1/96 | Verona | |||
| BLO | IMM | In vitro response to Phitoemoagglutinin | 1-13-97 | Padua | ||||
| BLO | IMM | bovine fetal serum | normal range | 1-13-97 | Padua | |||
| BLO | IMM | base | 537 | 470 +/- 301 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 10 ugr/ml | 41.483 | 141.310 +-24. | 1-13-97 | Padua | ||
| BLO | IMM | PHA 5 ugr/ml | 67.104 | 157.594+-23. | 1-13-97 | Padua | ||
| BLO | IMM | PHA 2,5 ugr/ml | 40.456 | 134.630+-10 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 1 ugr/ml | 54.045 | 50.114+-8.881 | 1-13-97 | Padua | ||
| BLO | IMM | autologus serum | 1-13-97 | Padua | ||||
| BLO | IMM | base | 405 | 870 +- 301 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 10 ugr/ml | 97.004 | 128.650+-27. | 1-13-97 | Padua | ||
| BLO | IMM | PHA 5 ugr/ml | 149.235 | 148.123+-25 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 2,5 ugr/ml | 159.235 | 128.734+-14 | 1-13-97 | Padua | ||
| BLO | IMM | PHA 1 ugr/ml | 43.095 | 59.125 +-8 | 1-13-97 | Padua | ||
| BLO | IMM | response to ConA | 1-13-97 | Padua | ||||
| BLO | IMM | ConA 2,5 mgr/ml | 17.306 | 1-13-97 | Padua | |||
| BLO | IMM | ConA 5 mgr/ml | 68.518 | 1-13-97 | Padua | |||
| BLO | IMM | ConA 20 mgr/ml | 160.975 | 1-13-97 | Padua | |||
| BLO | IMM | response to PWM | 1-13-97 | Padua | ||||
| BLO | IMM | PWM 0,5 mgr/ml | 93.736 | 1-13-97 | Padua | |||
| BLO | IMM | PWM 1 mgr/ml | 114.151 | 1-13-97 | Padua | |||
| BLO | IMM | PWM 2 mgr/ml | 95.807 | 1-13-97 | Padua | |||
| BLO | IMM | anti CD3 | 1-13-97 | Padua | ||||
| BLO | IMM | a-CD3 20 ngr/ml | 47.466 | 1-13-97 | Padua | |||
| BLO | IMM | IMMUNOLOGICAL MARKERS | 1-13-97 | Padua | ||||
| BLO | IMM | CD3 total T lymp. | 88 | (75%+- 5) | 1-13-97 | Padua | ||
| BLO | IMM | CD4 helper | 43 | (47%+-5) | 1-13-97 | Padua | ||
| BLO | IMM | CD8 T suppressor | 29 | (28%+-6) | 1-13-97 | Padua | ||
| BLO | IMM | RATIO CD4/CD8 | 1,5 | 1.8 +-0,7 | 1-13-97 | Padua | ||
| BLO | IMM | CD19 total B lymp. | 4 | 10%+-3 | 1-13-97 | Padua | ||
| BLO | IMM | CD5 total T lymp. | 90 | 70% +-6 | 1-13-97 | Padua | ||
| BLO | IMM | CD25 | 6 | <2% | 1-13-97 | Padua | ||
| BLO | IMM | SmIg total B lymp. | 5 | 9%+- 3 | 1-13-97 | Padua | ||
| BLO | IMM | CD56 N.K. | 9 | 13% +- 5 | 1-13-97 | Padua | ||
| BLO | IMM | CD16 N.K. | 9 | 13 % +-5 | 1-13-97 | Padua | ||
| BLO | IMM | CD57 | 10 | 17% +- 4 | 1-13-97 | Padua | ||
Home Page | Anita's Story | Physiotherapist's Report | Test Results | CAT and NMR scans | E-Mail
If you experience any problems viewing this site.
drop us an e-line at oracle@rialto.com